Breast Cancer

Posted by & filed under Uncategorized.

1 in 8 women in the US will develop breast cancer in their lifetime, but regular screening dramatically increases the odds of recovery. Breast cancer is a very complex disease, and each case is unique. At West Cancer Center & Research Institute our team of specialist understands that no two breast cancer cases are alike.... Read more »

Dr. Lee Schwartzberg on HER2– HR+ Breast Cancer: Tesetaxel & Capecitabine

Posted by & filed under Uncategorized.

Lee S. Schwartzberg, MD, of the West Cancer Center, discusses phase III results from the CONTESSA study, which showed that an all-oral regimen of tesetaxel plus a reduced dose of capecitabine significantly improved progression-free survival compared with capecitabine alone in patients with HER2-negative, hormone receptor–positive metastatic breast cancer previously treated with a taxane (Abstract GS4-01)…. Read more »